Screener
CONMED CNMD Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Proceeds from term loan | 450,000 | 25,234 |
| Payments on revolving line of credit | (402,000) | (337,432) |
| Proceeds from revolving line of credit | 595,000 | 341,432 |
| Repurchases of common stock | (43,221) | — |
| Payments to repurchase convertible notes | (637,176) | — |
| Payments related to contingent consideration | (28,853) | (14,094) |
| Payments related to debt issuance costs | (3,547) | (2,897) |
| Dividends paid on common stock | — | (12,366) |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's payments for repurchase of common stock?
- CONMED (CNMD) reported payments for repurchase of common stock of $6.2M in Q2 2026.
Ask your AI about CONMED's payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude